Companies
World Courier
A specialty pharma logistics leader advancing cell-and-gene-therapy trial logistics, often in partnership with CROs such as IQVIA.
- Country
- United States
GDP
IATA CEIV Pharma
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| cleanroom-facilities | ✓ | ✓ | — | ✓ |
| logistics-supply-chain | ✓ | ✓ | ✓ | ✓ |
| regulatory-legal | ✓ | ✓ | — | ✓ |
Regulatorsfdaemanmpausda-aphis
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Acquired by AmerisourceBergen (now Cencora) for $520 million in 2012. | investor.cencora.com |
| Headcount | 4,000+ employees worldwide | staff.uzh.ch · worldcourier.com |
| Certification | GDP certified by EMA, FDA, and WHO; ISO 9001, 14001, and 27001 certified. | staff.uzh.ch · worldcourier.com |
| Production site | 120+ company-owned facilities globally, including 22 GxP-compliant storage depots. | staff.uzh.ch · worldcourier.com |
| Regulatory approval | CFR 21 Part 11 compliant. | worldcourier.com |
Independent sources: investor.cencora.com · staff.uzh.ch
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bio import/export customs brokerage | regulatory-legal | Low | → |
| Biospecimen logistics for clinical trials | logistics-supply-chain | Low | → |
| Cold chain for cell & gene therapies | cleanroom-facilities | Low | → |
| Hazardous biomaterials transport (IATA Class 6.2) | logistics-supply-chain | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.